UNIVERSITY OF MARYLAND BALTIMORE;UNIVERSITY OF WASHINGTON;TOKAI PHARMACEUTICALS INC.
发明人:
申请号：
IL24341915
公开号：
IL243419D0
申请日:
2015.12.30
申请国别(地区):
IL
年份:
2016
代理人:
摘要：
Described herein are methods and compositions for the treatment of prostate cancer in a subject in need thereof. The prostate cancer may be a castration resistant and an androgen receptor antagonist-resistant prostate cancer. The methods may comprise administering to the subject a CYP17-lyase inhibitor of Formula II.
